vs
Side-by-side financial comparison of LANDSTAR SYSTEM INC (LSTR) and PERRIGO Co plc (PRGO). Click either name above to swap in a different company.
LANDSTAR SYSTEM INC is the larger business by last-quarter revenue ($1.2B vs $1.1B, roughly 1.1× PERRIGO Co plc). LANDSTAR SYSTEM INC runs the higher net margin — 3.4% vs -127.8%, a 131.2% gap on every dollar of revenue. On growth, LANDSTAR SYSTEM INC posted the faster year-over-year revenue change (1.6% vs -2.5%). Over the past eight quarters, PERRIGO Co plc's revenue compounded faster (1.3% CAGR vs -2.2%).
Landstar System, Inc. is an American transportation services company specializing in logistics and, more specifically, third-party logistics. Landstar utilizes an extensive network of over 8,800 independent owner-operators, referred to internally as business capacity owners (BCOs), over 1,000 independent freight agents, and over 70,000 vetted carriers. Landstar provides services principally throughout the United States and to a lesser extent in Canada and between the U.S. and Canada, Mexico, ...
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters ...
LSTR vs PRGO — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.2B | $1.1B |
| Net Profit | $39.4M | $-1.4B |
| Gross Margin | 9.6% | 32.6% |
| Operating Margin | 4.5% | -116.0% |
| Net Margin | 3.4% | -127.8% |
| Revenue YoY | 1.6% | -2.5% |
| Net Profit YoY | 32.3% | -3093.9% |
| EPS (diluted) | $1.16 | $-10.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.2B | — | ||
| Q4 25 | $1.2B | $1.1B | ||
| Q3 25 | $1.2B | $1.0B | ||
| Q2 25 | $1.2B | $1.1B | ||
| Q1 25 | $1.2B | $1.0B | ||
| Q4 24 | $1.2B | $1.1B | ||
| Q3 24 | $1.2B | $1.1B | ||
| Q2 24 | $1.2B | $1.1B |
| Q1 26 | $39.4M | — | ||
| Q4 25 | $23.9M | $-1.4B | ||
| Q3 25 | $19.4M | $7.5M | ||
| Q2 25 | $41.9M | $-8.4M | ||
| Q1 25 | $29.8M | $-6.4M | ||
| Q4 24 | $46.2M | $-44.4M | ||
| Q3 24 | $50.0M | $-21.0M | ||
| Q2 24 | $52.6M | $-108.4M |
| Q1 26 | 9.6% | — | ||
| Q4 25 | — | 32.6% | ||
| Q3 25 | — | 36.1% | ||
| Q2 25 | — | 34.4% | ||
| Q1 25 | — | 37.6% | ||
| Q4 24 | — | 33.9% | ||
| Q3 24 | — | 37.2% | ||
| Q2 24 | — | 37.0% |
| Q1 26 | 4.5% | — | ||
| Q4 25 | 2.5% | -116.0% | ||
| Q3 25 | 2.2% | 7.0% | ||
| Q2 25 | 4.6% | 4.3% | ||
| Q1 25 | 3.4% | 4.5% | ||
| Q4 24 | 4.8% | 10.0% | ||
| Q3 24 | 5.2% | 7.4% | ||
| Q2 24 | 5.6% | -2.5% |
| Q1 26 | 3.4% | — | ||
| Q4 25 | 2.0% | -127.8% | ||
| Q3 25 | 1.6% | 0.7% | ||
| Q2 25 | 3.5% | -0.8% | ||
| Q1 25 | 2.6% | -0.6% | ||
| Q4 24 | 3.8% | -3.9% | ||
| Q3 24 | 4.1% | -1.9% | ||
| Q2 24 | 4.3% | -10.2% |
| Q1 26 | $1.16 | — | ||
| Q4 25 | $0.70 | $-10.23 | ||
| Q3 25 | $0.56 | $0.05 | ||
| Q2 25 | $1.20 | $-0.06 | ||
| Q1 25 | $0.85 | $-0.05 | ||
| Q4 24 | $1.30 | $-0.32 | ||
| Q3 24 | $1.41 | $-0.15 | ||
| Q2 24 | $1.48 | $-0.79 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $411.0M | — |
| Total DebtLower is stronger | $26.1M | — |
| Stockholders' EquityBook value | $799.0M | $2.9B |
| Total Assets | $1.6B | $8.5B |
| Debt / EquityLower = less leverage | 0.03× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $411.0M | — | ||
| Q4 25 | $452.2M | — | ||
| Q3 25 | $434.4M | $432.1M | ||
| Q2 25 | $426.2M | $454.2M | ||
| Q1 25 | $473.4M | $409.9M | ||
| Q4 24 | $566.6M | $558.8M | ||
| Q3 24 | $531.3M | $1.5B | ||
| Q2 24 | $504.0M | $542.8M |
| Q1 26 | $26.1M | — | ||
| Q4 25 | $0 | — | ||
| Q3 25 | $0 | — | ||
| Q2 25 | $0 | — | ||
| Q1 25 | $0 | — | ||
| Q4 24 | $0 | — | ||
| Q3 24 | $0 | — | ||
| Q2 24 | $0 | — |
| Q1 26 | $799.0M | — | ||
| Q4 25 | $795.7M | $2.9B | ||
| Q3 25 | $888.7M | $4.4B | ||
| Q2 25 | $921.8M | $4.5B | ||
| Q1 25 | $930.8M | $4.4B | ||
| Q4 24 | $972.4M | $4.3B | ||
| Q3 24 | $1.0B | $4.6B | ||
| Q2 24 | $1.0B | $4.5B |
| Q1 26 | $1.6B | — | ||
| Q4 25 | $1.6B | $8.5B | ||
| Q3 25 | $1.7B | $10.1B | ||
| Q2 25 | $1.7B | $10.1B | ||
| Q1 25 | $1.7B | $9.8B | ||
| Q4 24 | $1.8B | $9.6B | ||
| Q3 24 | $1.8B | $11.2B | ||
| Q2 24 | $1.8B | $10.4B |
| Q1 26 | 0.03× | — | ||
| Q4 25 | 0.00× | — | ||
| Q3 25 | 0.00× | — | ||
| Q2 25 | 0.00× | — | ||
| Q1 25 | 0.00× | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | 0.00× | — | ||
| Q2 24 | 0.00× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $175.4M |
| Free Cash FlowOCF − Capex | — | $148.6M |
| FCF MarginFCF / Revenue | — | 13.4% |
| Capex IntensityCapex / Revenue | — | 2.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $145.1M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $72.7M | $175.4M | ||
| Q3 25 | $89.3M | $51.7M | ||
| Q2 25 | $7.1M | $75.9M | ||
| Q1 25 | $55.7M | $-64.5M | ||
| Q4 24 | $61.1M | $312.6M | ||
| Q3 24 | $83.1M | $42.2M | ||
| Q2 24 | $48.1M | $9.5M |
| Q1 26 | — | — | ||
| Q4 25 | $70.5M | $148.6M | ||
| Q3 25 | $86.0M | $29.8M | ||
| Q2 25 | $4.7M | $56.7M | ||
| Q1 25 | $53.8M | $-90.0M | ||
| Q4 24 | $54.4M | $274.9M | ||
| Q3 24 | $75.6M | $15.1M | ||
| Q2 24 | $40.6M | $-18.9M |
| Q1 26 | — | — | ||
| Q4 25 | 6.0% | 13.4% | ||
| Q3 25 | 7.1% | 2.9% | ||
| Q2 25 | 0.4% | 5.4% | ||
| Q1 25 | 4.7% | -8.6% | ||
| Q4 24 | 4.5% | 24.2% | ||
| Q3 24 | 6.2% | 1.4% | ||
| Q2 24 | 3.3% | -1.8% |
| Q1 26 | — | — | ||
| Q4 25 | 0.2% | 2.4% | ||
| Q3 25 | 0.3% | 2.1% | ||
| Q2 25 | 0.2% | 1.8% | ||
| Q1 25 | 0.2% | 2.4% | ||
| Q4 24 | 0.6% | 3.3% | ||
| Q3 24 | 0.6% | 2.5% | ||
| Q2 24 | 0.6% | 2.7% |
| Q1 26 | — | — | ||
| Q4 25 | 3.04× | — | ||
| Q3 25 | 4.61× | 6.89× | ||
| Q2 25 | 0.17× | — | ||
| Q1 25 | 1.87× | — | ||
| Q4 24 | 1.32× | — | ||
| Q3 24 | 1.66× | — | ||
| Q2 24 | 0.91× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LSTR
Segment breakdown not available.
PRGO
| Consumer Self Care Americas | $697.0M | 63% |
| Digestive Health | $123.9M | 11% |
| Nutrition | $108.3M | 10% |
| Healthy Lifestyle | $94.8M | 9% |
| Pain And Sleep Aids | $87.1M | 8% |
